Biblio Discovery — Demo Discovery Service

11 hasil untuk "Manuel Modolell"

Menampilkan 1–11 · 0,79 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Phenotypic Alteration of Neutrophils in the Blood of HIV Seropositive Patients

    Tom Cloke; Markus Munder; Philip Bergin dkk.

    PLoS ONE, Vol. 8 No. 9 · 2013 · Inggris · PLOS Scopus

    We have recently identified a novel population of activated low-density granulocytes (LDGs) in peripheral blood mononuclear cells of HIV seropositive patients. LDGs have a similar morphology to normal density granulocytes (NDGs), but are phenotypically different. Here we measured the expression…

  2. Artikel Jurnal Teks lengkap

    Age-Related Alteration of Arginase Activity Impacts on Severity of Leishmaniasis

    Ingrid Müller; Asrat Hailu; Beak-San Choi dkk.

    PLoS Neglected Tropical Diseases, Vol. 2 No. 5 · 2008 · Inggris · PLOS Scopus

    Background: The leishmaniases are a group of vector-borne parasitic diseases that represent a major international public health problem; they belong to the most neglected tropical diseases and have one of the highest rates of morbidity and mortality. The clinical outcome of infection with…

  3. Artikel Jurnal Teks lengkap

    Mitochondria and lipid raft-located F O F 1 -ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine

    Janny A. Villa-Pulgarín; Consuelo Gajate; Javier Botet dkk.

    PLOS Neglected Tropical Diseases, Vol. 11 No. 8 · 2017 · Inggris · PLOS Scopus

    Background: Leishmaniasis is the world’s second deadliest parasitic disease after malaria, and current treatment of the different forms of this disease is far from satisfactory. Alkylphospholipid analogs (APLs) are a family of anticancer drugs that show antileishmanial activity, including the first…

  4. Artikel Jurnal Teks lengkap

    Local Suppression of T Cell Responses by Arginase-Induced L-Arginine Depletion in Nonhealing Leishmaniasis

    Manuel Modolell; Beak-San Choi; Robert O. Ryan dkk.

    PLoS Neglected Tropical Diseases, Vol. 3 No. 7 · 2009 · Inggris · PLOS Scopus

    The balance between T helper (Th) 1 and Th2 cell responses is a major determinant of the outcome of experimental leishmaniasis, but polarized Th1 or Th2 responses are not sufficient to account for healing or nonhealing. Here we show that high arginase activity, a hallmark of nonhealing disease, is…

  5. Artikel Jurnal Teks lengkap

    Arginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV Infection

    Yegnasew Takele; Tamrat Abebe; Teklu Weldegebreal dkk.

    PLoS Neglected Tropical Diseases, Vol. 7 No. 1 · 2013 · Inggris · PLOS Scopus

    Background: Visceral leishmaniasis is a parasitic disease associated with high mortality. The most important foci of visceral leishmaniasis in Ethiopia are in the Northwest and are predominantly associated with high rates of HIV co-infection. Co-infection of visceral leishmaniasis patients with HIV…

  6. Artikel Jurnal Teks lengkap

    Local Increase of Arginase Activity in Lesions of Patients with Cutaneous Leishmaniasis in Ethiopia

    Tamrat Abebe; Asrat Hailu; Mihretu Woldeyes dkk.

    PLoS Neglected Tropical Diseases, Vol. 6 No. 6 · 2012 · Inggris · PLOS Scopus

    Background: Cutaneous leishmaniasis is a vector-borne disease that is in Ethiopia mainly caused by the parasite Leishmania aethiopica. This neglected tropical disease is common in rural areas and causes serious morbidity. Persistent nonhealing cutaneous leishmaniasis has been associated with poor T…

  7. Artikel Jurnal Teks lengkap

    In Vitro and In Vivo Efficacy of Ether Lipid Edelfosine against Leishmania spp. and SbV-Resistant Parasites

    Rubén E. Varela-M; Janny A. Villa-Pulgarin; Edward Yepes dkk.

    PLoS Neglected Tropical Diseases, Vol. 6 No. 4 · 2012 · Inggris · PLOS Scopus

    Background: The leishmaniases are a complex of neglected tropical diseases caused by more than 20 Leishmania parasite species, for which available therapeutic arsenal is scarce and unsatisfactory. Pentavalent antimonials (SbV) are currently the first-line pharmacologic therapy for leishmaniasis…

  8. Artikel Jurnal Teks lengkap

    Arginase Activity - A Marker of Disease Status in Patients with Visceral Leishmaniasis in Ethiopia

    Tamrat Abebe; Yegnasew Takele; Teklu Weldegebreal dkk.

    PLoS Neglected Tropical Diseases, Vol. 7 No. 3 · 2013 · Inggris · PLOS Scopus

    The underlying mechanisms resulting in the profound immune suppression characteristic of human visceral leishmaniasis (VL) are not fully understood. Here, we tested the hypothesis that arginase, an enzyme associated with immunosuppression, is higher in patients with VL and contributes to impaired T…

  9. Artikel Jurnal Teks lengkap

    Disease severity in patients with visceral leishmaniasis is not altered by co-infection with intestinal parasites

    Fitsumbrhan Tajebe; Mulusew Getahun; Emebet Adem dkk.

    PLOS Neglected Tropical Diseases, Vol. 11 No. 7 · 2017 · Inggris · PLOS Scopus

    Visceral leishmaniasis (VL) is a neglected tropical disease that affects the poorest communities and can cause substantial morbidity and mortality. Visceral leishmaniasis is characterized by the presence of Leishmania parasites in the spleen, liver and bone marrow, hepatosplenomegaly, pancytopenia…

  10. Artikel Jurnal Teks lengkap

    Successful Treatment of Human Visceral Leishmaniasis Restores Antigen-Specific IFN-γ, but not IL-10 Production

    Emebet Adem; Fitsumbirhan Tajebe; Mulusew Getahun dkk.

    PLOS Neglected Tropical Diseases, Vol. 10 No. 3 · 2016 · Inggris · PLOS Scopus

    One of the key immunological characteristics of active visceral leishmaniasis (VL) is a profound immunosuppression and impaired production of Interferon-γ (IFN-γ). However, recent studies from Bihar in India showed using a whole blood assay, that whole blood cells have maintained the capacity to…